Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

Last updated: May 3, 2018

CMS Measure ID: CMS22v6
Version: 6
NQF Number: None
Measure Description:

Percentage of patients aged 18 years and older seen during the reporting period who were screened for high blood pressure AND a recommended follow-up plan is documented based on the current blood pressure (BP) reading as indicated

Initial Patient Population:

All patients aged 18 years and older before the start of the measurement period with at least one eligible encounter during the measurement period

Denominator Statement:

Equals Initial Population

Denominator Exclusions:

Patient has an active diagnosis of hypertension

Numerator Statement:

Patients who were screened for high blood pressure AND have a recommended follow-up plan documented, as indicated if the blood pressure is pre-hypertensive or hypertensive

Numerator Exclusions:

Not Applicable

Denominator Exceptions:

Patient Reason(s):

Patient refuses to participate (either BP measurement or follow-up)

OR

Medical Reason(s):

Patient is in an urgent or emergent medical situation where time is of the essence and to delay treatment would jeopardize the patient's health status. This may include but is not limited to severely elevated BP when immediate medical treatment is indicated.

Measure Steward: Centers for Medicare and Medicaid Services (CMS)
Domain: Community/Population Health
Next Version:
Previous Version:
Improvement Notation:

Higher score indicates better quality

Guidance:

Both the systolic and diastolic blood pressure measurements are required for inclusion. If there are multiple blood pressures on the same date of service, use the most recent as the representative blood pressure.

Eligible professionals or eligible clinicians who report the measure must perform the blood pressure screening at the time of a qualifying visit by an eligible professional or eligible clinician and may not obtain measurements from external sources.

The intent of this measure is to screen patients for high blood pressure and provide recommended follow-up as indicated. The documented follow-up plan must be related to the current BP reading as indicated, example: Patient referred to primary care provider for BP management.

Notes: Value Set content updated Sept 2017

Specifications

Release Notes

Header

  • ​Incremented eMeasure Version number.

    Measure Section: eMeasure Version number

    Source of Change: Measure Lead

  • Modified Measure Developer name from 'Quality Insights of Pennsylvania' to 'Quality Insights.'.

    Measure Section: Measure Developer

    Source of Change: Measure Lead

  • ​Updated Copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Updated Guidance.

    Measure Section: Guidance

    Source of Change: Measure Lead

  • Updated References.

    Measure Section: Reference

    Source of Change: Measure Lead

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Value set Laboratory Tests for Hypertension (2.16.840.1.113883.3.600.1482): Added 1 LOINC code (24320-4).

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set BP Screening Encounter Codes (2.16.840.1.113883.3.600.1920): Deleted 7 CPT codes (90832, 90834, 90837, 90839, 90845, 90880, 96118).

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set Anti-Hypertensive Pharmacologic Therapy (2.16.840.1.113883.3.600.1476): Added 12 RXNORM codes and deleted 18 RXNORM codes.

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set Anti-Hypertensive Pharmacologic Therapy (2.16.840.1.113883.3.600.1476): Added 4 RXNORM codes (1923422, 1923424, 1923426, 901446) and deleted 28 RXNORM codes.

    Measure Section: QDM Data Elements

    Source of Change: 2018 Addendum

External Resources